Clinical trial Recruiting at 2 sites Observational Ages 18 and up Women only

Collection of biological samples from patients with pelvic gynecological cancer and endometriosis

Official title: Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization

Run by Centre Hospitalier Intercommunal Creteil · NCT03622983 · Data updated 2026-11-12

This study is collecting samples from patients with pelvic gynecological cancers and endometriosis to see if they can find clues that help predict cancer recurrence and improve personalized treatments.

More Endometriosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment500 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Locations2 sites (Créteil and 1 other locations)
StatusRecruiting
StartedMay 1, 2017
Main results expectedAugust 2027
Study endsAugust 2037
Registry record updatedDecember 21, 2022
Trial IDNCT03622983 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with a diagnosis of pelvic gynecological cancer or endometriosis.

Probably not a fit

Patients who refuse to participate or are not affiliated with the general social security scheme may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to collect biological samples and detailed clinical data from patients diagnosed with pelvic gynecological cancers and endometriosis. By analyzing these samples, researchers hope to identify factors that predict cancer recurrence and develop personalized treatment strategies based on the biological characteristics of the tumors. The study focuses on the evolving biology of pelvic cancers and the potential for personalized medicine, particularly in relation to anti-PARP therapy for ovarian cancer. The findings could enhance understanding and management of these conditions.

Why it matters

Potential benefit: If successful, this study could lead to more effective, personalized treatment options for patients with pelvic gynecological cancers and endometriosis.

How similar studies have gone: Other studies have shown promising results in identifying predictive factors for recurrence in similar conditions, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence;
* Or diagnosis of endometriosis on histology or imaging
* Age ≥ 18 years;
* Affiliation to the general social security scheme;
* Consent signed.

Exclusion Criteria:

* Refusal of the patient;
* Non-affiliation to the general social security scheme.

Where it's running

  • CHI Creteil
    Créteil, France
    Recruiting
  • CHU Tenon
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.